oral nitrate reductase activity is not associated with development of non- alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis(nash): a pilot study

Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study

BACKGROUND NAFLD/NASH is a manifestation of metabolic syndrome and is associated with obesity/overweight. Not all obese/overweight individuals develop NASH. Gastro-esophageal reflux disease (GERD) is considered a gastrointestinal manifestation of the metabolic syndrome and is associated with obesity/overweight. Again not all obese/overweight individuals develop GERD. Recent data show associatio...

Alcoholic Hepatitis, Alcoholic Cirrhosis & Non-Alcoholic Fatty Liver Disease (NAFLD)

Non-alcoholic Fatty Liver Disease (NAFLD)

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in Western countries in which men and women are affected equally (de Alwis and Day 2008; Willner et al. 2001). The prevalence and severity of NAFLD increase with obesity (Flegal et al. 1998 & 2003). Since obesity is known to have a genetic etiology, we propose that genetic factors influence susceptibility...

Prevalence of gallstone disease in the patients with non-alcoholic fatty liver disease (NAFLD) in Sanandaj: A case control study

Background and Aim: Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) are both highly prevalent in the general population and have many risk factors in common. The aim of this study was to evaluate the prevalence of GD in the patients with NAFLD. Materials and Methods: In this case-control study, our case group included 145 patients with NAFLD and control group consisted of 21...

Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease

Background & Objective: Nonalcoholic fatty liver diseases (NAFLD) is the major cause of hepatocellular carcinoma and increases the risk of mortality. Understanding the trends of its clinical and biochemical changes is essential to identify patients with NAFLD that are at the greatest risk of nonalcoholic steatohepatitis (NASH) and cirrhosis in Iran. M...

The effect of Ramadan fasting on non-alcoholic fatty liver disease (NAFLD) patients

Purpose: The aim of this study was to compare biochemical tests, body composition and anthropometric parameters in Nonalcoholic Fatty Liver Disease (NAFLD) patients before and after Ramadan fasting. Methods: fifty NAFLD patients including 33 males and 17 females aged 18-65 year, were recruited. Subjects attended after diagnosis based on  ultrasound imaging, with at least 10 hour fasting, before...